Product Information
AMLODIPINE-ATORVAST 2.5-20 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.4967 per EA under NDC 62332075630. Its NADAC has been published 23 times since Jan 21, 2026.
Strength
2.5; 20 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332075630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA217279On Market Since
5/23/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 2.5-20 MG has been published 23 times since Jan 21, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4967 per EA |
|---|---|
| All-time high | $4.4967 (Jun 24, 2026) |
| All-time low | $4.4967 (Jan 21, 2026) |
| 52-week high | $4.4967 |
| 52-week low | $4.4967 |
| Median price | $4.4967 |
| Average price | $4.4967 |
| Largest weekly change | 0.0% (Jan 28, 2026) |
| Weeks tracked | 23 |
| Tracking since | Jan 21, 2026 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 2.5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 2.5-20 MG, manufactured by Alembic Pharmaceuticals Inc., is $4.4967 per EA (NDC 62332075630), effective Jun 24, 2026.
How has the price of AMLODIPINE-ATORVAST 2.5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 2.5-20 MG has held within roughly two percent of its current level. It has been tracked across 23 weekly CMS publications since Jan 21, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 2.5-20 MG?
Since Jan 21, 2026, the NADAC for AMLODIPINE-ATORVAST 2.5-20 MG has ranged from a low of $4.4967 (Jan 21, 2026) to a high of $4.4967 (Jun 24, 2026), with a median of $4.4967 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 2.5-20 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-ATORVAST 2.5-20 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 2.5-20 MG?
AMLODIPINE-ATORVAST 2.5-20 MG (NDC 62332075630) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification